Abstrakt: |
Arialys Therapeutics, a clinical-stage biotechnology company pioneering new precision medicines for autoimmune neuropsychiatry, today announced the appointment of Sankalp “Sam” Gokhale, M.D., as Chief Medical Officer. Dr. Gokhale is a U.S. board-certified neurologist with over 15 years of clinical practice and pharmaceutical industry experience. He has extensive expertise in all phases of clinical development, specifically in rare disease neurology indications. [ABSTRACT FROM PUBLISHER] |